Fecal tumor M2 pyruvate kinase is not a specific biomarker for colorectal cancer screening

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

214

HTML

1189

Tables (1-1)

205

Sum=1608

May 21, 2007 (publication date) through Feb 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letters To The Editor

World J Gastroenterol. May 21, 2007; 13(19): 2768-2769
Published online May 21, 2007. doi: 10.3748/wjg.v13.i19.2768

Full Size Figure Download Figure

$[Label] $[Caption_0] $[Caption_1]

Citation: Shastri YM, Stein JM. Fecal tumor M2 pyruvate kinase is not a specific biomarker for colorectal cancer screening. World J Gastroenterol 2007; 13(19): 2768-2769
URL: https://www.wjgnet.com/1007-9327/full/v13/i19/2768.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i19.2768